CB12 Awarded ‘Number 1 Product for Innovative Product Launch 2013’ Alliance Boots Awards 2013
On 3rd July this year, Alliance Boots held their annual supplier conference, with all their major suppliers across the healthcare, beauty and baby industries in attendance.
Recognised as the Number 1 product for ‘Innovative Product Launch’ was CB12, acknowledged for its product uniqueness and the effectiveness of the marketing support utilised at the launch.
With ‘bad breath’ found to be in the top five most embarrassing conditions to discuss[i], CB12 provides an effective solution to eliminate both the physical and physiological effects for suffers. The winning mouth rinse formula neutralises the VSCs (Volatile Sulphur Compounds) responsible for malodorous breath, relieving suffers of symptoms for up to 12 hours.
Supplied by Meda Pharmaceuticals, the team are delighted to have faired so well against the industry giants, and would like to thank to all who helped make this possible.
To see what CB12 could do for your patients, please visit www.cb12.co.uk
About the author
Related Posts
Comments
By accepting you will be accessing a service provided by a third-party external to https://www.gdpuk.com/
GDPUK Ltd announces sale of intellectual property to leading publisher Cogora Group
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands, events and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
Tony will continue involvement in GDPUK on a consulting basis.
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.